How a Paid Activist Group Destroyed the Fight for Legal MDMA - 5CAST (#12) ft. Hamilton Morris

Quick Overview

A paid activist group called Symposia, allegedly funded by the pharmaceutical company Eona, successfully interfered with the FDA's plan to legalize MDMA for PTSD therapy after clinical trials showed high remission rates, primarily by launching a multi-year cancel campaign against figures in the MDMA world using progressive language to attack progressive causes.

Key Points: The FDA advisory panel pulled the plug on MDMA legalization for PTSD therapy following external pressure from Symposia, despite clinical trials showing around 80% of participants achieving significant remission. Hamilton Morris highlights the extreme and contradictory behavior of core Symposia members, including one who allegedly advised engaging in "terrorist tactics" against Eona's competitor, Compass. Symposia's campaign utilized accusations like "gentrification of consciousness," sexual misconduct claims, and cultural appropriation, often rooted in what Morris calls the "entrepreneurship of psychedelic negativity." Eona, funded by biotech company Promega, allegedly used Symposia and a specific Vice blogger, Shayla Love, to spread negative press about its competitor, Compass, while simultaneously incentivizing MAPS to halt drug policy reform work. The activist group Symposia ultimately self-destructed due to internal accusations of impropriety, proving the danger of funding "uncontrollable" and "seriously insane" extremist groups for corporate bidding. Morris details his own history with Vice, noting its pivot from a counterculture literary magazine under Jesse Pearson to a news entity where fact-checking prioritized limiting legal liability over establishing truth, making it a "perfect tool" for Eona's disinformation. MDMA therapy trials, arranged by MAPS and led by Rick Doblin, showed 67% of participants losing their PTSD diagnosis after just a few sessions, but the process was derailed partly due to an isolated incident of therapist sexual abuse and external sabotage.

Context: The discussion centers on the collapse of the effort to legalize MDMA for PTSD treatment, featuring guest Hamilton Morris, a documentarian and chemist known for his work on psychoactive drugs including his series "Hamilton's Pharmacopia." The conversation focuses on the role of a specific activist organization, Symposia, and its alleged financial ties to the pharmaceutical company Eona, which contrasted sharply with the positive clinical outcomes achieved by MAPS (Multidisciplinary Association for Psychedelic Studies) in their MDMA trials.